The advanced lung cancer inflammation index predicts chemotherapy response and infection risk in multiple myeloma patients receiving induction chemotherapy
J Cheng, Q Li, S Xiao, L Nie, J Liao, Q Jiang… - Frontiers in …, 2022 - frontiersin.org
Objective: This study aims to determine the clinical significance of the advanced lung cancer
inflammation index (ALI) in predicting prognosis, chemotherapy response, and infection risk …
inflammation index (ALI) in predicting prognosis, chemotherapy response, and infection risk …
流式微球阵列技术鉴别诊断多发性骨髓瘤患者感染状态及类型的价值
胡姗姗， 黄黎， 罗信国， 朱艳 - 临床血液学杂志, 2024 - lcxy.whuhzzs.com
目的探析流式微球阵列技术(cytometric bead array, CBA) 鉴别诊断多发性骨髓瘤(multiple
myeloma, MM) 患者感染状态及类型的价值. 方法采用回顾性队列研究方法, 收集2019 年1 月 …
myeloma, MM) 患者感染状态及类型的价值. 方法采用回顾性队列研究方法, 收集2019 年1 月 …
[HTML][HTML] Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and …
SI Kim, SH Jung, HY Yhim, JC Jo, GY Song, M Kim… - Blood …, 2022 - ncbi.nlm.nih.gov
Background Although survival outcomes of multiple myeloma (MM) have improved with the
development of new and effective agents, infection remains the major cause of morbidity …
development of new and effective agents, infection remains the major cause of morbidity …
Value of cytometry microsphere array technology in differential diagnosis of infection status and types in patients with multiple myeloma
HU Shanshan, H Li, LUO Xinguo, ZHU Yan - J Clin Hematol, 2024 - lcxyen.whuhzzs.com
Value of cytometry microsphere array technology in differential diagnosis of infection status and
types in patients with multiple myeloma Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} …
types in patients with multiple myeloma Homepage Journals 1.{{journal.titleEn}} {{journal.titleEn}} …